BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 21561866)

  • 21. Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells.
    Li H; Zhang H; Huang G; Bing Z; Xu D; Liu J; Luo H; An X
    J Exp Clin Cancer Res; 2022 Jan; 41(1):33. PubMed ID: 35073964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2.
    Dai MS; Sun XX; Lu H
    Mol Cell Biol; 2008 Jul; 28(13):4365-76. PubMed ID: 18426907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ribosomal protein S7 is both a regulator and a substrate of MDM2.
    Zhu Y; Poyurovsky MV; Li Y; Biderman L; Stahl J; Jacq X; Prives C
    Mol Cell; 2009 Aug; 35(3):316-26. PubMed ID: 19683495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26.
    Ofir-Rosenfeld Y; Boggs K; Michael D; Kastan MB; Oren M
    Mol Cell; 2008 Oct; 32(2):180-9. PubMed ID: 18951086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in vivo.
    Saville MK; Sparks A; Xirodimas DP; Wardrop J; Stevenson LF; Bourdon JC; Woods YL; Lane DP
    J Biol Chem; 2004 Oct; 279(40):42169-81. PubMed ID: 15280377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control.
    Li L; Liao J; Ruland J; Mak TW; Cohen SN
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1619-24. PubMed ID: 11172000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of HDM2 and activation of p53 by ribosomal protein L23.
    Jin A; Itahana K; O'Keefe K; Zhang Y
    Mol Cell Biol; 2004 Sep; 24(17):7669-80. PubMed ID: 15314174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Splicing-factor oncoprotein SRSF1 stabilizes p53 via RPL5 and induces cellular senescence.
    Fregoso OI; Das S; Akerman M; Krainer AR
    Mol Cell; 2013 Apr; 50(1):56-66. PubMed ID: 23478443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defect in the p53-Mdm2 autoregulatory loop resulting from inactivation of TAF(II)250 in cell cycle mutant tsBN462 cells.
    Wasylyk C; Wasylyk B
    Mol Cell Biol; 2000 Aug; 20(15):5554-70. PubMed ID: 10891494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depletion of ribosomal protein L37 occurs in response to DNA damage and activates p53 through the L11/MDM2 pathway.
    Llanos S; Serrano M
    Cell Cycle; 2010 Oct; 9(19):4005-12. PubMed ID: 20935493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acrolein preferentially damages nucleolus eliciting ribosomal stress and apoptosis in human cancer cells.
    Wang HT; Chen TY; Weng CW; Yang CH; Tang MS
    Oncotarget; 2016 Dec; 7(49):80450-80464. PubMed ID: 27741518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of p53 and MDM2 activity by MTBP.
    Brady M; Vlatkovic N; Boyd MT
    Mol Cell Biol; 2005 Jan; 25(2):545-53. PubMed ID: 15632057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ribosomal protein S27-like and S27 interplay with p53-MDM2 axis as a target, a substrate and a regulator.
    Xiong X; Zhao Y; He H; Sun Y
    Oncogene; 2011 Apr; 30(15):1798-811. PubMed ID: 21170087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PIM1 destabilization activates a p53-dependent response to ribosomal stress in cancer cells.
    Sagar V; Caldarola S; Aria V; Monteleone V; Fuoco C; Gargioli C; Cannata S; Loreni F
    Oncotarget; 2016 Apr; 7(17):23837-49. PubMed ID: 26993775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of Actinomycin D induced upregulation of Mdm2 in H1299 cells.
    Li L; Cui D; Zheng SJ; Lou H; Tang J
    DNA Repair (Amst); 2012 Feb; 11(2):112-9. PubMed ID: 22051195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perturbation of RNA Polymerase I transcription machinery by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells.
    Turi Z; Senkyrikova M; Mistrik M; Bartek J; Moudry P
    Cell Cycle; 2018; 17(1):92-101. PubMed ID: 29143558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 gene family p51(p63)-encoded, secondary transactivator p51B(TAp63alpha) occurs without forming an immunoprecipitable complex with MDM2, but responds to genotoxic stress by accumulation.
    Okada Y; Osada M; Kurata S; Sato S; Aisaki K; Kageyama Y; Kihara K; Ikawa Y; Katoh I
    Exp Cell Res; 2002 Jun; 276(2):194-200. PubMed ID: 12027449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HEY1 functions are regulated by its phosphorylation at Ser-68.
    López-Mateo I; Arruabarrena-Aristorena A; Artaza-Irigaray C; López JA; Calvo E; Belandia B
    Biosci Rep; 2016 Jul; 36(3):. PubMed ID: 27129302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mdm2 mutant defective in binding p300 promotes ubiquitination but not degradation of p53: evidence for the role of p300 in integrating ubiquitination and proteolysis.
    Zhu Q; Yao J; Wani G; Wani MA; Wani AA
    J Biol Chem; 2001 Aug; 276(32):29695-701. PubMed ID: 11340074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
    Lu X; Ma O; Nguyen TA; Jones SN; Oren M; Donehower LA
    Cancer Cell; 2007 Oct; 12(4):342-54. PubMed ID: 17936559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.